HOME


    2010 Senior Symposium Program
 

The CT Chapter of ASCP presents an annual Senior Symposium, a forum to educate, update and provide networking with professionals dedicated to caring for our elderly. This meeting is not just for Senior Care Pharmacists but also is appropriate for all members of the geriatric interdisciplinary team including Doctors, Nurses, Social Workers, Home Care professionals, Rehabilitative Therapists, Geriatric Living Facility Directors and Administrators and many more...
 
Accreditation/CE Information [Click Here]
Faculty [Click here]
Program Schedule [Click here]

 

Thursday, April 8th  

 12:00 noon  Registration Opens  Location: Pre-Function 1

1:45pm - 3:15 pm
LAW CE:
An Update for Long-term Care Pharmacists

ACPE#009-999-10-010-L03-P   0.15 CEU (1.5 contact hours) - Knowledge-based CE
Speakers: John Cannarella, RPh; John Gadea, RPh; Mike Gemma, RPh; Kevin Hill; Gene Memoli, RPh; Larry Sobel, RPh
Location: Premier GH
 

Learning Objectives
• Identify the reason(s) for new legislation for the prescribing of controlled substances in long-term care environments
• Describe the recent and pending legislation impacting pharmacy practice in long-term care for 2010

3:15pm - 3:30 pm Break
3:30 pm - 4:30 pm
CT-ASCP Board of Directors
Transition (ASCP members)
Location: Premier F 

4:30 pm - 5:45 pm
Pre-Dinner Reception
(Non-CE Event)
Understanding Gout as a Chronic Disease
Speaker: Joseph Croft MD

Location: Premier A
Sponsored by TAKEDA Pharmaceutical Company

5:45 pm - 6:30 pm
Dinner & opening Remarks
Location: Premier BD 

6:30 pm - 8:00 pm
Hypertension in the Elderly: Too Little, Too Late?
ACPE #009-999-10-011-L01-P   0.15CEU (1.5 contact hours) - Knowledge-based CE
Speakers: Marvin Moser, MD

Learning Objectives
• Identify barriers to the optimal care of the elderly patient with hypertension and other comorbidities
• Critically analyze both the risk and benefit of current treatments for hypertension in the elderly patient with
   hypertension and other geriatric syndromes
• Describe how to initiate discussion of the risks and benefits of treatment and total costs in older patients
   with hypertension and other comorbidities

This presentation is generously supported by an educational grant from FOREST Laboratories., Inc.

download handout

8:30 pm
Evening at Shrine Lounge & Nightclub -
Networking
Friday, April 9th
5:30 am
Registration Opens  Location: Pre-Function 1
6:00 am - 7:00 am
Eye Opener: A Case Study in Chronic Low Back Pain –
Pain Management with Skeletal Muscle Relaxants and Non-opioid Analgesics

ACPE #: 009-999-10-012-L01-P   0.1 CEU (1 contact hour) - Application-based CE
Speaker:
Kevin W. Chamberlin, PharmD

Location: Premier A

Learning Objectives
• Identify common misconceptions about chronic back pain patients and treatment with prescription non-opioid
  analgesics and skeletal muscle relaxants (SMRs)
• Describe differences and barriers surrounding choices between prescription non-opioid analgesics and skeletal muscle relaxants
  (SMRs) used in chronic back pain management

download handout

7:00 am - 8:00 am
Breakfast Product Theater 1
(Non-CE Event)
Neuropathic Pain of Postherpetic Neuralgia and Herpes Zoster
• Integrating New Clinical Data into a Comprehensive PHN Pain Management
• Patient Presentation: 73-year-old retired, previously active, man with ongoing sharp pain with skin sensitivity.

Speaker: Michael J.. Brennan MD
Locations: Premier EF
Sponsored by ENDO Pharmaceuticals

 

7:00 am - 8:00 am
Breakfast Product Theater 2
(Non-CE Event)
Topic: TBA
Speaker: TBA
Locations: Premier GH
Sponsored by AMGEN

8:15 am - 9:45 am
Opening General Session
LAW CE
Here Come the Feds: Understanding Washington's Increasing Role in Pharmacy Practice
ACPE#
009-999-10-013-L03-P    0.15 CEU )(1.5 contact hours) - Knowledge-based CE
Speaker: Claudia Schlosberg, JD
Location: Premier BD

Learning Objectives

• Recall the historic role of the federal government in the regulation of pharmacy and the key drivers that are contributing
  to a more active role
• Identify significant current issues that have the potential to change pharmacy practice and the challenges and opportunities
  that pharmacists and pharmacies are likely to face
• Identify tools to help you be more effective in communicating with policy makers regarding the critical role that pharmacists
  play in our health care system

download handout

9:45pm - 10:00 am Break
Location: Exibit hall
10:00 am - 11:30am
Second General Session
Annual Timothy Webster Memorial Address: What Comes Next? New Models of Practice - New Models of Care
ACPE #009-999-10-014-L04-P   0.15 CEU (1.5 contact hours) - Knowledge-based CE
Speaker: William Thomas, MD
Location: Premier BD


Learning Objectives

• Describe how aging is transforming the healthcare system
• Define the central role that Pharmacists will play on managing patients with multiple co-morbidities
•
Explain the opportunities for innovation and exploration within the health care system

11:30 am - 1:00 pm

Product Theater Luncheon 1
(Non-CE Event)
Location: Premier EF
Sponsored by TAKEDA Pharmaceutical Company
Treatment of Chronic Constipation in the Elderly
Speaker: Dana Saffel, PharmD


11:30 pm - 1:00 pm
Product Theater Luncheon 2
(Non-CE Event)
Location: Premier GH
Sponsored by CENTOCOR ORTHO BIOTECH
Anemia Identification & Management in the Elderly
Overview:
Anemia is prevalent in the long‐term care setting and is undiagnosed and may not be treated. Anemia
is not a normal part of aging and is an important disease that may be associated with negative
outcomes. Causes of anemia include decreased red blood cell production, increased red blood cell
destruction, and blood loss. This presentation will address appropriate identification, assessment and
management of anemia in the elderly population
Learning Objectives:
• Highlight the prevalence of anemia in the elderly and in the long‐term care (LTC) setting
• Provide an overview of the consequences and associations of anemia in the elderly
• Review the workup and management of anemia

• Discuss LTC‐related considerations in the identification and management of anemia

1:00 pm - 2:00 pm
General Session
New Medications, New generics, New FDA labeling... More Work
ACPE #009-999-10-015-L01-P   0.1 CEU (1 contact hour) - Knowledge-based CE
Speaker: Nancy Losben, RPh
Location: Premier BD

Learning Objectives
• Explain the initiatives of the FDA Risk Evaluation and Mitigation Strategies
• Describe how to monitor patients for dose, adverse effects and drug-drug interactions using new drugs to treat chronic disease
• Outline how to appropriately distribute and/or use FDA approve medication guides in the assisted living population
• Describe how to use new drug labeling warnings in monitoring drug side effects
• Explain how to access readily available new drug information as soon as available

download handout

2:00 pm - 3:00 pm
Exhibit Hall & Dessert
Location: Exhibit Hall
3:00 pm - 4:00 pm
When is Anticoagulation Worth the Risk? Managing Older Atrial Fibrillation Patients
ACPE #
009-999-10-016-L01-P
0.10 CEU (1 contact hour)
Knowledge-based CE
Speaker: Sean Jeffery, PharmD
Location: Premier A

Learning Objectives

• Describe the risks and benefits of
  treatment options, including warfarin
  alternatives
• Describe the co-morbidities and geriatric
  syndromes common among older adults
  with AF and understand the need to take
  an individualized management approach to
  care
• Discuss the management of AF
  pharmacologically with the awareness of
  polypharmacy issues

download handout

3:00 pm - 4:00 pm
Compounding: Custom Dosage
Forms for Long-term Care Patients
ACPE #009-999-10-017-L04-P
0.10 CEU (1 contact hour)
Knowledge-based CE
Speakers: Robin Bogner, PhD
                Michael Lettmoden, PharmD
Location: Premier EF

Learning Objectives

• Describe how compounding can help
  develop customized dosage forms for
  delivering medications to challenging
  patients
• Demonstrate how to establish “beyond
  use dates” for extemporaneously
  compounded medications

 

 

 

 

download handout

3:00 pm - 4:00 pm
Why Adults Only? The Public Health case for Adult Immunization
ACPE #009-999-10-018-L04-P
0.10 CEU (1 contact hour)
Knowledge-based CE

Speaker: Thomas Buckley, RPh, MPH
Location: Premier GH

Learning Objectives

• Describe the cost-effective impact of
  immunization
• Explain the reasons for the vaccination
  gap between child and adult immunization
• Describe the role of pharmacists in
  immunization advocacy
• Identify and resolve public health
  immunization issues

 

 

 

 

download handout

4:00 pm - 4:15 pm Break 
4:15 pm - 5:15 pm
Health Literacy & Aging

ACPE #009-999-10-019-L04-P
0.10 CEU (1 contact hour)
Knowledge-based CE
Speakers: Erica Estus, PharmD
Location: Premier A

Learning Objectives

• Define health literacy and discuss the
  significance of the age related changes
  that occur in older adults
• Summarize evidence regarding the
  relationship between literacy and health
  outcomes in specific disease processes
• Discuss strategies, tools, and materials
  intended to improve communication
  between patients and providers

 

 

 


 

 

download handout
 

4:15 pm - 5:15 pm
Medication Errors: The Drug Use
Process & the Elderly
ACPE #009-999-10-020-L05-P
0.10 CEU (1 contact hour)
Knowledge-based CE

Speaker: Dennis Chapron, RPh, MS
Location: Premier EF

Learning Objectives

• Explain the difference between an adverse
  drug event, adverse drug reactions, and a
  medication error
• List the components of the drug use
  process that are not involved in the
  medication errors.
• Describe a process for evaluating a
  patient’s medication profile and its risk for
  causing an adverse drug event
• Describe some breakdown points that may
  lead to omissions-type medication errors
• Develop a drug monitoring process for
  lithium, amiodarone, and methotrexate.

 

download handout

4:15 pm - 5:15 pm

Topic: DNA Guided Psychotropic
Management
ACPE #009-999-10-021-L04-P
0.10 CEU (1 contact hour)
Knowledge-based CE
Speaker: Gualberto Ruano, MD, PhD
Location: Premier GH

Learning Objectives

• Recognize the clinical utility of cytochrome
  P450 (CYP450) genotyping in management
  of psychiatric drugs

• Recognize the case presentations and
  patient profiles where use of CYP450
  genotyping can diagnose clinically intensive
  side effects
• Identify healthcare utilization patterns in
  patients with CYP450 drug metabolism
  deficiencies
• Recall the features of next-generation
  multi-genotype arrays to diagnose and
  prevent the cardiometabolic and
  neuroendocrine side effects of
  antipsychotic drugs

download handout

 

 

Copyright © 2004 CTASCP